Tianfeng Securities: maintains a "buy" rating for PharmaDynamics Group (09885.HK) High gross profit margin and proprietary products are expected to continue bringing incremental profits.

According to the intelligence Finance APP, Tianfeng Securities released a research report stating that they maintain a "buy" rating for Pharmacist's Helper (09885.HK) and have raised their forecasted net profit attributable to shareholders for 2025-2027 from 1.56/3.73/6.02 billion yuan to 1.79/4.03/6.50 billion yuan. In 2025H1, the company's platform + self-operated business performed steadily, and the company's own brand business achieved good breakthroughs. High-margin self-owned varieties are expected to continue to bring incremental profits. In 2025H1, the company achieved operating income of 9.843 billion yuan, a year-on-year increase of 11.66%; achieved net profit attributable to shareholders of 0.78 billion yuan, a year-on-year increase of 258.01%; achieved non-recurring net profit attributable to shareholders of 0.78 billion yuan, a year-on-year increase of 1602.64%.